Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients
- PMID: 19379613
- DOI: 10.2500/ajra.2009.23.3263
Correlation of severity of epistaxis with nasal telangiectasias in hereditary hemorrhagic telangiectasia (HHT) patients
Abstract
Background: Hereditary hemorrhagic telangiectasia (HHT), also known as Rendu-Osler-Weber syndrome, is an autosomal dominant disease that leads to multiregional angiodysplasia. The presence of telangiectasias in nasal mucosa leads to recurrent epistaxis that affects up to 96% of patients but with unpredictable severity. Some authors have previously explained that endonasal morphology and distribution of telangiectasias can be variable too. The purpose of this study was to evaluate any possible relationship between the severity of epistaxis and the different morphology and distribution of nasal telangiectasias in HHT patients.
Methods: A review was performed of nasal endoscopy records of 76 consecutive HHT patients treated for epistaxis between 2003 and 2007 at our institution. An evaluation was performed of severity of epistaxis in the same patient group using a questionnaire and considering frequency, intensity, duration of nosebleeds, and need for blood transfusions. Comparison of data collected on morphology and distribution of nasal telangiectasias with data collected on severity of epistaxis was performed.
Results: Morphology and distribution of nasal telangiectasias showed a statistically significant correlation with frequency and intensity of epistaxis. Presence of telangiectasias endoscopically appearing as large and prominent correlates with higher frequency of epistaxis. An increase in number of nasal subsites involved correlates with higher intensity of nosebleeds.
Conclusion: Our data suggest that to reduce frequency and intensity of epistaxis in HHT patients, treatments should be directed also at lesions located in the posterior part of nasal fossae and especially on telangiectasias endoscopically appearing as large and prominent.
Similar articles
-
Morphology and distribution of nasal telangiectasia in HHT-patients with epistaxis.Am J Rhinol. 2005 Jan-Feb;19(1):65-70. Am J Rhinol. 2005. PMID: 15794077
-
New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia.Am J Rhinol. 2006 Jan-Feb;20(1):87-90. Am J Rhinol. 2006. PMID: 16539301
-
Lack of significant estrogen and progesterone receptor expression in nasal telangiectasias in hereditary hemorrhagic telangiectasia: an immunohistochemical analysis.Acta Otolaryngol. 2012 Jan;132(1):86-9. doi: 10.3109/00016489.2011.621145. Epub 2011 Nov 6. Acta Otolaryngol. 2012. PMID: 22185213
-
Hereditary haemorrhagic telangiectasia.Haemophilia. 2008 Nov;14(6):1269-80. doi: 10.1111/j.1365-2516.2008.01774.x. Haemophilia. 2008. PMID: 19141168 Review.
-
Clinical Practice Guideline: Nosebleed (Epistaxis) Executive Summary.Otolaryngol Head Neck Surg. 2020 Jan;162(1):8-25. doi: 10.1177/0194599819889955. Otolaryngol Head Neck Surg. 2020. PMID: 31910122 Review.
Cited by
-
Endoscopic surgical treatment of epistaxis in hereditary haemorrhagic telangiectasia: our experience.Acta Otorhinolaryngol Ital. 2021 Feb;41(1):59-68. doi: 10.14639/0392-100X-N0915. Acta Otorhinolaryngol Ital. 2021. PMID: 33746224 Free PMC article.
-
Silicone septal splint for recurrent epistaxis in HHT patients: experience of a national referral centre.Acta Otorhinolaryngol Ital. 2023 Apr;43(Suppl. 1):S28-S33. doi: 10.14639/0392-100X-suppl.1-43-2023-03. Acta Otorhinolaryngol Ital. 2023. PMID: 37698097 Free PMC article.
-
A retrospective analysis of low dose, intranasal injected bevacizumab (Avastin) in hereditary haemorrhagic telangiectasia.Eur Arch Otorhinolaryngol. 2012 Feb;269(2):531-6. doi: 10.1007/s00405-011-1721-9. Epub 2011 Jul 31. Eur Arch Otorhinolaryngol. 2012. PMID: 21805356
-
Efficacy and safety of thalidomide for the treatment of severe recurrent epistaxis in hereditary haemorrhagic telangiectasia: results of a non-randomised, single-centre, phase 2 study.Lancet Haematol. 2015 Nov;2(11):e465-73. doi: 10.1016/S2352-3026(15)00195-7. Epub 2015 Oct 27. Lancet Haematol. 2015. PMID: 26686256 Free PMC article. Clinical Trial.
-
Classification of endonasal HHT lesions using digital microscopy.Orphanet J Rare Dis. 2021 Apr 17;16(1):182. doi: 10.1186/s13023-021-01801-9. Orphanet J Rare Dis. 2021. PMID: 33865423 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources